Patent Application
Utility
App. No. 17/865,707
· Confirmation No. 5636
METHODS OF USING INHALED NITRIC OXIDE GAS FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME IN CHILDREN
Applicant:
Mallinckrodt Pharmaceuticals Ireland Limited
Expressly Abandoned -- During Examination
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2025-08-14 | OATH |
Oath or Declaration filed | 75 | View | |
| 2024-05-08 | ABN |
Abandonment | 2 | View | |
| 2024-05-02 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2024-05-02 | EABN |
Letter Express Abandonment of the application | 2 | View | |
| 2023-02-02 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2022-12-21 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 8 | View | |
| 2022-12-21 | FOR |
Foreign Reference | 18 | View | |
| 2022-12-21 | FOR |
Foreign Reference | 38 | View | |
| 2022-12-21 | FOR |
Foreign Reference | 13 | View | |
| 2022-12-21 | FOR |
Foreign Reference | 26 | View | |
| 2022-12-21 | FOR |
Foreign Reference | 32 | View | |
| 2022-12-21 | REF.OTHER |
Other reference-Patent/Application/Search Documents | 8 | View | |
| 2022-12-21 | REF.OTHER |
Other reference-Patent/Application/Search Documents | 9 | View | |
| 2022-12-21 | N417 |
Electronic Filing System Acknowledgment Receipt | 7 | View | |
| 2022-10-11 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2022-10-11 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2022-10-06 | PEFR |
Applicant Response to Pre-Exam Formalities Notice | 1 | View | |
| 2022-10-06 | SPEC |
Specification | 1 | View | |
| 2022-10-06 | REM |
Applicant Arguments/Remarks Made in an Amendment | 1 | View | |
| 2022-10-06 | SPEC |
Specification | 79 | View | |
| 2022-10-06 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2022-08-09 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2022-08-09 | NT.CR.APP.PA |
Notice to File Corrected Application Papers | 2 | View | |
| 2022-08-09 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2022-07-15 | PA.. |
Power of Attorney | 1 | View | |
| 2022-07-15 | SPEC |
Specification | 78 | View | |
| 2022-07-15 | CLM |
Claims | 4 | View | |
| 2022-07-15 | ABST |
Abstract | 1 | View | |
| 2022-07-15 | DRW |
Drawings-only black and white line drawings | 6 | View | |
| 2022-07-15 | ADS |
Application Data Sheet | 8 | View | |
| 2022-07-15 | OATH |
Oath or Declaration filed | 2 | View | |
| 2022-07-15 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2022-07-15 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View |
Inventors
Jim Potenziano
Binghamton, NY
Ronald Bronicki
Houston, TX
Attorneys & Agents of Record
Classification
USPC
424/718
A61K33/00
A61K9/007
Prosecution
- Examiner
- WITZ, JEAN C
- Art Unit
- 3991
- Customer No.
- 24289
- Docket No.
- H-IK-30049T.1 (-724738)
- Confirmation No.
- 5636
Publication
- Pub. No.
- US20230033881A1
- Pub. Date
- 2023-02-02
Parent
is a Continuation in-part of
→
App. 17/458,202
Filed 2021-08-26
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Reissue of
→
App. 16/217,981
· US 10,391,120
Filed 2018-12-12
· Patented Case
Parent
is a Continuation of
→
App. 15/170,130
· US 10,201,564
Filed 2016-06-01
· Patented Case
Parent
is a Continuation of
→
App. 14/593,085
· US 9,381,212
Filed 2015-01-09
· Patented Case
Parent
Claims priority from a provisional application
→
App. 61/925,925
Filed 2014-01-10
· Provisional Application Expired
Parent
Claims priority from a provisional application
→
App. 63/222,092
Filed 2021-07-15
· Provisional Application Expired
MALLINCKRODT ENTERPRISES LLC,
MALLINCKRODT LLC,
MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY,
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED,
OCERA THERAPEUTICS LLC,
SPECGX LLC,
STRATATECH CORPORATION,
SUCAMPO PHARMA AMERICAS LLC,
VTESSE LLC
RELEASE OF SECURITY INTEREST
Recorded 2025-08-14
MALLINCKRODT INTERNATIONAL FINANCE S.A.,
MALLINCKRODT CB LLC,
MALLINCKRODT FINANCE GMBH,
MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.),
MALLINCKRODT CARRIBEAN, INC.,
MALLINCKRODT US POOL LLC,
MNK 2011 LLC (F/K/A MALLINCKRODT INC.),
LUDLOW LLC (F/K/A LUDLOW CORPORATION),
CNS THERAPEUTICS, INC.,
MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.),
MALLINCKRODT ENTERPRISES LLC,
MALLINCKRODT LLC,
LAFAYETTE PHARMACEUTICALS LLC,
LIEBEL-FLARSHEIM COMPANY LLC,
MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.),
MALLINCKRODT VETERINARY, INC.,
MALLINCKRODT US HOLDINGS LLC,
IMC EXPLORATION COMPANY,
MEH, INC.,
MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED),
MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED),
OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.),
SPECGX LLC,
STRATATECH CORPORATION,
SUCAMPO PHARMA AMERICAS LLC,
VTESSE LLC (F/K/A VTESSE INC.),
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED,
MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.),
INFACARE PHARMACEUTICAL CORPORATION,
ST SHARED SERVICES LLC,
THERAKOS, INC.,
IKARIA THERAPEUTICS LLC,
INO THERAPEUTICS LLC
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 064709, FRAME 0055
Recorded 2023-11-16
OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.),
MALLINCKRODT LLC,
SPECGX LLC,
STRATATECH CORPORATION,
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
RELEASE OF SECURITY INTERESTS IN PATENTS AT REEL 064709/FRAME 0111
Recorded 2023-11-15
from
MALLINCKRODT ENTERPRISES LLC,
MALLINCKRODT LLC,
MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY,
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED,
OCERA THERAPEUTICS LLC,
SPECGX LLC,
STRATATECH CORPORATION,
SUCAMPO PHARMA AMERICAS LLC,
VTESSE LLC
SECURITY INTEREST
Recorded 2023-11-15
from
MALLINCKRODT LLC,
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED,
OCERA THERAPEUTICS, INC.,
SPECGX LLC,
STRATATECH CORPORATION
SECURITY INTEREST
Recorded 2023-08-25
from
MALLINCKRODT LLC,
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED,
OCERA THERAPEUTICS, INC.,
SPECGX LLC,
STRATATECH CORPORATION
SECURITY INTEREST
Recorded 2023-08-25
from
MALLINCKRODT LLC,
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED,
OCERA THERAPEUTICS, INC.,
SPECGX LLC,
STRATATECH CORPORATION
SECURITY INTEREST
Recorded 2023-08-25
from
THERAKOS, INC.
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2023-03-22
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2023-03-22
from
MALLINCKRODT IP
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2023-03-22
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2023-03-22
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2023-03-22
CHANGE OF NAME
Recorded 2023-03-22
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2023-03-22
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 17/865,707
- Filed
- 2022-07-15
- Pub. No.
- US20230033881A1
- Examiner
- WITZ, JEAN C
- Art Unit
- 3991
External Links